Received Apr 21, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
fever; Congestion; Tiredness; Chills; Rashes; This non-serious case was reported by a consumer and described the occurrence of fever in a 58-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. The patient's past medical history included chickenpox (chicken pox at age 18 and it was severe.). On 23-MAR-2026, the patient received Shingrix. On 23-MAR-2026, less than a day after receiving Shingrix, the patient experienced fever (Verbatim: fever), congestion nasal (Verbatim: Congestion), tiredness (Verbatim: Tiredness), chills (Verbatim: Chills) and rash (Verbatim: Rashes). The outcome of the fever, congestion nasal, tiredness, chills and rash were not resolved. It was unknown if the reporter considered the fever, congestion nasal, tiredness, chills and rash to be related to Shingrix. It was unknown if the company considered the fever, congestion nasal, tiredness, chills and rash to be related to Shingrix. Additional Information: GSK Receipt Date: 10-APR-2026 The patient was completely healthy with no significant medical history other than that patient had chicken pox at age 18 and it was severe. The patient experienced severe congestion, tiredness, fever, chills and rashes. The batch number was not provided and a request for this information has been made.
Medical History/Concurrent Conditions: Chickenpox (chicken pox at age 18 and it was severe.)